Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, andZollinger-Ellison syndrome.

 Omeprazole, not Mingluosaike, is a way to effectively inhibit gastric acid secretion proton pump inhibitors. There protease inhibition of gastric secretion of gastric mucosal blood flow change is not obvious, does not affect body temperature, stomach cavity temperature, arterial blood pressure, venous hemoglobin, arterial oxygen, carbon dioxide partial pressure and arterial blood pH.  

Binds covalently to proton pump. It inhibits gastric secretion. Used as an anttiulcerative

1. Peptic ulcer bleeding and anastomotic ulcer bleeding;

2. Acute gastric mucosal injury complicated by stress and acute gastric mucosal injury caused by nonsteroidal anti-inflammatory drugs;
3. Prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.) stress state and upper gastrointestinal bleeding caused by gastric surgery;
4. As an alternative when oral therapy is not appropriate for duodenal ulcer, gastric ulcer, reflux esophagitis, and zollinger-ellison syndrome;
5.Applied in pharmaceutical filed, drugs inhibiting gastric acid secretion.